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In-hospital Mortality Characteristics of Women 
With Acute Myocardial Infarction
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Abstract
Background: Cardiovascular disease continues to be the leading 
cause of death in women and men in the United States. This study 
aimed to investigate differences in characteristics between those 
women who died and survived an acute myocardial infarction (MI).
Methods: This secondary analysis included 109 women. Demo-
graphic variables were extracted along with presenting MI symp-
toms, cardiovascular risk factors (family history of cardiovascular 
disease, patient history of cardiovascular disease, diabetes, hyper-
cholesterolemia, hypertension, and smoking history), type of MI, 
time of symptom onset and time of presentation to emergency de-
partment (ED) for treatment. Descriptive statistics described the 
sample,  t-tests  and  chi-square  analyzed  differences  between  the 
groups. 
Results: There was a 12% mortality rate for women experiencing 
an acute MI. The women who died had a mean age of 79 years, ap-
proximately 7 years older than those who survived (P = 0.037). The 
leading MI presenting symptoms were chest pain and shortness of 
breath. The mean number of cardiovascular risk factors for those 
who died were 2.15 compared to 2.75 for those who survived (P = 
0.063). The majority of those women who survived had a non ST 
Elevation MI (94%) compared to 54% with a non ST Elevation MI 
who died. Median time to ED presentation was 242.5 minutes for 
those who survived compared to 244 minutes who died (P = 0.951). 
Conclusions: These data demonstrate a MI mortality profile of 
women which included an older age, no family history of heart 
disease reported, and a high rate of hypertension. Those who died 
reported chest pain and shortness of breath, with several presenting 
with a syncopal event. In addition, the women represented in this 
sample had a prolonged presentation time for treatment. 
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Introduction
Cardiovascular  (CV)  disease  continues  to  be  the  leading 
cause of mortality for women and men in the United States 
(US), with 4.7 million men and 3.2 million women diag-
nosed with acute myocardial infarction (MI) in 2006 [1]. 
A MI occurs where the myocardium has damage due to an 
inadequate supply of oxygen [2]. Diagnosis is made by the 
presence of two of the three findings:  symptoms characteris-
tic of MI; electrocardiogram (ECG) changes consistent with 
MI; and/or an increase and decrease of cardiac enzymes. The 
two major types of MIs are ST elevation MI (STEMI) and 
Non-ST elevation MI (NSTEMI). STEMIs have the charac-
teristic ST elevation on the ECG indicating myocardial tis-
sue death. NSTEMIs occur when there is temporary block-
age of the coronary artery causing myocardial tissue death, 
but are less extensive than STEMIs. 
Since the 1990s, inclusion of women in CV research 
has  determined  similarities  and  differences  between  the 
genders. Both genders have the same major risk factors for 
heart disease, such as cigarette smoking, hypercholesterol-
emia, hypertension, diabetes mellitus, and family history of 
CV disease. However, previous research determined of those 
women suffering a MI only about half had been diagnosed 
with CV risk factors prior to their MI, demonstrating a lack 
of screening for risk factors [3]. Studies have shown women 
and men have different MI symptoms. Women tend to report 
more back and jaw pain, dyspnea and fatigue in comparison 
to men who have more chest pain and diaphoresis [4, 5]. 
In addition, previous studies have determined differenc-
es in mortality between women and men after an acute MI 
[6, 7]. STEMI mortality continues to be higher than NSTE-
MI, with higher mortality for STEMI in women and African 
Americans [8]. Women with NSTEMI who had numerous 
CV risk factors had a higher mortality rate and received less 
aggressive  treatments  than  men  [9].  Treatment  delays  in 
women with an acute MI have been documented [10-13], 
possibly contributing to morbidity and mortality. An earlier 
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study determined female sex and STEMI as predictors of in-
hospital MI mortality [14]. Although the in-hospital mortal-
ity rate is 9.4% in the US [15], a recent study determined 
a higher rate of in-hospital morality among women (12%) 
compared to men (7%) [16]. In this study we aimed to inves-
tigate differences between women who died and those who 
survived an acute MI.
 
Patients and Methods
Patients
  
The parent study was a retrospective chart review conducted 
at a private, 1200-bed academic medical center that include 
273 patients, 109 women and 164 men [16]. Inclusion cri-
teria were adult patients with a discharge diagnosis of acute 
MI. A list of patients with an International Classification of 
Diseases and Related Health Problems (ICD-9) for acute MI 
was obtained for the period January 1, 2004 and December 
31, 2004. The list contained 348 patients that were randomly 
selected for inclusion. This secondary analysis included 109 
women. The study was conducted after approval from the 
Institutional Review Board; no identifiers were included or 
available. Demographic variables were extracted including 
age,  ethnicity,  presenting  MI  symptoms,  CV  risk  factors 
(family history of cardiovascular disease, patient history of 
cardiovascular disease, diabetes, hypercholesterolemia, hy-
pertension, and smoking history). A positive smoking history 
was considered if the patient reported smoking cigarettes 
within the past year prior to MI admission. STEMIs were 
further divided into type: anterior/lateral wall MI, anterior 
wall MI (AWMI), inferior/lateral wall MI, and inferior wall 
MI (IWMI). Time of symptom onset and time of presenta-
tion to the emergency department (ED) were extracted and 
recorded from the ED intake form. All data were extracted 
Total Females 
(n = 109)
Females Survived
(n = 96)
Females Died
(n = 13)
P Value
Age Mean = 73
(SD = 14.54)
Mean = 72 
(SD = 14.86) 
Mean = 79 
(SD = 10.27)
0.037
Ethnicity
     Caucasian
     African American
     Hispanic
     Asian
     Other
n             %
70           64
25           23
6             6
1             1
7             6
n          %   
62        66
23        23
4           4
0           0
7           7
n          %
8          62
2          15
2          15
1           8
0           0
< 0.0001
Leading Presenting Symptoms
     Chest pain
     Shortness of breath
     Syncope
n              %
54            50
23            21    
5               5
n           %
51         53
21         22
1            1
n           %
3           23
2           15
4           31
0.021
Risk Factors
     Family history heart disease
     Patient history heart disease 
     Diabetes
     Hypercholesterolemia
     Hypertension
     Smoking history
n             %
15           14
93           85
30           28
51          47
99          91
4            4
n           %
15         15
82         85
28         29
47         49
88         92
4             4
n           %
0            0
11         85
2           15
4           31
11         85
 0            0
< 0.0001
Mortality 13          12  
Table 1. Demographic and Cardiovascular Risk Factors
t-test analyzed differences between continuous variables; chi-square analyzed differences between categorical variables.
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by the principal investigator (LAM). 
Statistics
Data were analyzed using SPSS 17. Descriptive statistics in-
cluding means, medians and standard deviations were used 
to describe the sample. The t test analyzed differences in 
continuous variables. Chi-Square analysis was used to deter-
mine differences in categorical variables. An alpha of 0.05 
was set.
 
Results
Demographics
For the overall sample, the mean age of women was 73 years 
(SD = 14.54) (Table 1). Sixty four percent were Caucasian 
(n = 70). The leading presenting symptoms for the group 
were chest pain (n = 54, 50%) and shortness of breath (n = 
23, 21%). A majority of the women reported a prior history 
of cardiovascular disease (n = 93, 85%). Over half of the 
patients had hypercholesterolemia with 91% reporting a his-
tory of hypertension. Twelve percent of the women died dur-
ing the MI hospitalization (n = 12). The mean age for those 
who survived was 72 years (SD = 14.86) compared to those 
who died with a mean age of 79 (SD = 10.27), P = 0.04. The 
majority of those who died were Caucasian (62%).
Cardiovascular risk factors, time to ED presentation and 
mortality
Six major CV risk factors were recorded. Of those women 
who survived a majority had a history of heart disease (85%) 
and hypertension (92%), with about half reporting hypercho-
lesterolemia (49%) (Table 1). The only women who reported 
smoking were those who survived the acute MI. In contrast, 
those women who died had no report of a family history of 
heart disease. Eighty five percent of those who died had a 
history of heart disease and hypertension. The mean number 
of CV risk factors for those who died were 2.15 compared to 
2.75 for those who survived (P = 0.063).
Of the 109 women included in the study, 10 had their 
MIs after admission to the hospital. Therefore, they could 
not be included in the time difference between symptom 
onset and presentation time to the ED. The median time of 
onset for the 99 women was 244 minutes. Of the 88 who sur-
vived the median time to ED presentation was 242.5 minutes 
compared to 244 minutes for the 11 who died. Comparison 
of mean ED presentation time differences was not signifi-
cantly different (P = 0.951).
Type of MI, presenting MI symptoms and mortality
The majority of those women who survived had a NSTEMI 
(94%) compared to 54% with a NSTEMI who died (Table 
2). Of those who died, 3 had an AWMI and 3 had IWMI. In 
comparison, in those who survived one had an anterior/lat-
eral wall MI, 5 AWMI, and one inferior/lateral MI. Over half 
(53%) of those women who survived had chest pain as their 
presenting MI symptom and 22% had shortness of breath. 
For those who died 23% had chest pain; 15% reported short-
ness of breath; and 31% had syncope.
Discussion
  
The results of this study described similarities and differ-
ences between those women who survived an acute MI and 
those who died. Those women who died were about 7 years 
older than those who survived, yet the mortality group ex-
ceeded US female life expectancy rates. When these data 
were collected the mean age of those who died was 79 years; 
the average life expectancy age for women in the US was 
77.8 years [17]. The majority of women in this sample were 
Caucasian, including those who died. Only 15% of those 
who died were African American. Therefore, no sub analysis 
could be performed to determine if mortality was higher in 
African Americans as previously reported [8].
More CV risk factors increase the likelihood of suffering 
a MI, especially in women [18]. Interestingly, those who died 
actually had lower mean CV risk factors. Our study showed 
that the majority of those who died had hypertension and a 
history of heart disease. For history of heart disease, there 
was not a breakdown into subcategories to determine what 
diseases constituted heart disease history, such as previous 
MI or acute coronary syndromes. Although a breakdown was 
not collected on subgroups for those who reported heart dis-
ease, prior heart disease could have contributed to death. The 
diagnosis of hypertension was considerably high, 85%. In 
the US, the total female population has a 32.1% hypertension 
rate [15]. One interesting finding was none of the women 
who died reported a family history of heart disease. Knowing 
Females 
Survived
(n = 96) 
Females 
Died
(n = 13)
P Value
MI Type
   STEMI
   NSTEMI
n        %
90      94
6        6
n        %
6        46
7        54
< 0.0001
MI: myocardial infarction; STEMI: ST elevation MI; NSTEMI: Non-
ST elevation MI.
Table 2. MI Type and Mortality
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the genetic and familial contribution to heart disease this is 
surprising. Some explanations may be related to participants 
not knowing their specific family history. Although it was a 
very small percentage, of those who reported smoking in the 
past year, none of these women were in the group that died.
The women who died had different presenting symp-
toms than those who survived. About one-third of those who 
died presented with a syncopal episode, compared to only 
one (1%) participant in the group who survived. A previous 
study determined that using a rule out MI protocol for those 
who reported syncope as a presenting symptom to the ED 
yielded a low diagnosis of MI [19]. Although there are mul-
tiple etiologies of syncope, MI is a possible cause and in our 
study an initial symptom of syncope resulted in a MI diag-
nosis and ultimately these women died. Although previous 
studies have determined that women experience different MI 
symptoms than men [5], our study demonstrated that over 
half of those who survived had chest pain and one-fourth 
with chest pain died. The presentation of chest pain may 
have prompted expedient MI care than other less “classic” 
MI symptoms. 
Time from MI symptom onset to presentation for treat-
ment is a critical time period. The “Golden Hour” is consid-
ered the first 60 minutes after MI onset where reperfusion 
of the myocardium can prevent mortality, an ultimate 120 
minute goal for reperfusion with either fibrinolysis or percu-
taneous coronary intervention (PCI) is recommended [20]. 
Door to balloon refers to the time a patient with a STEMI 
enters the ED to time to first PCI balloon inflation which is 
recommended in 90 minutes or less. Door to needle refers 
to the time the patient arrives to the ED with a STMEI to 
time fibrinolysis infusion begins, with a goal of one hour or 
less [20]. Fibrinolysis is recommended to begin within 180 
minutes of MI. Both the mortality (P = 0.013) and survival 
(P < 0.0001) groups significantly fell out of the 120 minute 
goal to reperfusion. The mean 330 minutes in the group that 
died may have ultimately contributed to their death. Con-
tinual education of MI symptom identification and prompt 
medical treatment is necessary to improve the time to treat-
ment intervals.
Although  STEMIs  generally  have  a  higher  mortality 
than NSTEMI [8], there was an approximate 50/50 split in 
STEMI  versus  NSTEMI  mortality. As  previously  stated, 
reperfusion is ideally initiated in the first 120 minutes of 
an acute MI [20]. With the increased presentation time to 
the ED, the 120 minute treatment timeframe could not be 
achieved in this sample. Treatments and time to treatment 
(door to balloon or door to needle) were not collected in the 
original study.
In summary, limitations to this study include the retro-
spective design and the small number of women in the mor-
tality group along with the limited ethnic diversity. We did 
not collect or control for treatments which could contribute 
to mortality. These data demonstrate a MI mortality profile 
of women which included an older age, no family history of 
heart disease, and a high rate of hypertension. Those who 
died did have chest pain and shortness of breath, with sev-
eral presenting with a syncopal event. In addition, the wom-
en represented in this sample had a prolonged presentation 
time for treatment, which may have contributed to mortality. 
More research, including treatments, needs to be conducted 
to continue to improve mortality rates among women with 
MI.
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